Your browser doesn't support javascript.
loading
Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
Wang, Yumeng; Wang, Congwen; Qiu, Junjun; Qu, Xinyu; Peng, Jing; Lu, Chong; Zhang, Meng; Zhang, Mingxing; Qi, Xingling; Li, Guiling; Hua, Keqin.
Afiliación
  • Wang Y; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Wang C; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Qiu J; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Qu X; Department of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Peng J; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Lu C; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Zhang M; Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Zhang M; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Qi X; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Li G; Department of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Hua K; Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
J Immunother Cancer ; 10(3)2022 03.
Article en En | MEDLINE | ID: mdl-35288463

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido